5 gestern neue bestätigte Fälle von Nasenabstrichen in Heilongjiang

5 gestern neue bestätigte Fälle von Nasenabstrichen in Heilongjiang

Im Februar 4, 2021, Die Global Times gab bekannt, dass Heilongjiang gestern hinzugefügt habe 5 bestätigte Nasenabstriche und 3 neue asymptomatische Infektionen.

5 Neu bestätigte Fälle einer neuen Koronarpneumonie in der Provinz Heilongjiang, 2 Fälle (1 im Landkreis Wangkui, Stadt Suihua, 1 Fall im Bezirk Hulan, Stadt Harbin) were asymptomatic infections converted to confirmed cases, 2 Fälle ( Wangkui County, Stadt Suihua) was found in the nucleic acid screening of key populations, und 1 Fall (Limin Development Zone, Stadt Harbin) was found in the nucleic acid test of close contacts in the centralized isolation point; a new cure was added that day 26 confirmed cases were discharged from hospital (21 im Landkreis Wangkui, Stadt Suihua, 3 in Hailun City, 1 in Daoli District, Harbin, und 1 in Longfeng District, Daqing City); 3 new cases of asymptomatic infection were added that day (1 im Landkreis Wangkui, Stadt Suihua) Cases, 1 case in Daowai District, Stadt Harbin, 1 Fall im Bezirk Hulan), both were discovered during the nucleic acid test of close contacts in the centralized isolation point; 28 cases of asymptomatic infection were released on the same day (Wangkui County, Stadt Suihua) 22 Fälle, 1 case in Hailun City, 2 cases in Ang’angxi District of Qiqihar City, 2 cases in Fulaerji District, 1 case in Limin Development Zone of Harbin City).

Ab 24:00 on February 4, 2021, there are currently 441 confirmed cases in the province (4 severe cases, 309 common cases, und 128 mild cases); es gibt 447 asymptomatische Infektionen.

The newly confirmed cases and asymptomatic infections mentioned above have been isolated for treatment or isolated medical observation in designated medical institutions. The relevant local authorities have implemented control measures for all close contacts identified in the discharge, and carried out terminal disinfection of their lives and workplaces.

Quelle: People’s Daily Client